The standard warnings for this drug class include: Hypoglycemia: Retatrutide increases the risk of hypoglycemia (low blood sugar level) when taken with other glucose-lowering medications such as insulin or sulfonylurea
Common side effects include: Cognitive slowing, including difficulties with memory, concentration, and word-finding Fatigue and drowsiness Dizziness and coordination problems Paraesthesia (tingling sensations, particularly in the hands and feet) Decreased appetite and weight loss Mood changes, including low mood, depression, and irritability More serious risks include: Metabolic acidosis topiramate inhibits carbonic anhydrase, which can reduce blood bicarbonate levels
You were temporarily placed on a lower dose to resolve side effects
In a study focusing on semaglutide as a treatment for T2D, it even reduced hemoglobin A1C
2015;39:S23S35
It also suppresses glucagon secretion, slows gastric emptying, and promotes satiety, which collectively contribute to lower blood sugar levels